SEARCH

SEARCH BY CITATION

References

  • 1
    Minnema MC, Fijnheer R, Groot de PG, Lokhorst HM. Extremely high levels of Von Willebrand factor antigen and of procoagulant factor VIII found in multiple myeloma patients are associated with activity status but not with thalidomide treatment. J Thromb Haemost 2003; 1: 4459.DOI: 10.1046/j.1538-7836.2003.00083.x
  • 2
    Glaspy JA. Hemostatic abnormalities in multiple myeloma and related disorders. Hematol Oncol Clin North Am 1992; 6: 130114.
  • 3
    Mohri H, Tanabe J, Ohtsuka M, Yoshida M, Motomura S, Nishida SY, Fuijmura Okubo T. Acquired Von Willebrand disease associated with multiple myeloma: characterisation of an inhibitor to Von Willebrand factor. Blood Coagul Fibrinolysis 1995; 6: 5616.
  • 4
    Zangari M, Anaissie E, Barlogie B, Badros A, Desikan R, Viju Gopal A, Morris C, Toor A, Siegel E, Fink L, Tricot G. Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy. Blood 2001; 98: 161415.
  • 5
    Zangari M, Siegel E, Barlogie B, Anaissie E, Saghafifar F, Fassas A, Morris C, Fink L, Tricot G. Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy. Blood 2002; 100: 116871.
  • 6
    Kamphuisen PW, Eikenboom JC, Bertina RM. Elevated factor VIII levels and the risk of thrombosis. Arterioscler Thromb Vasc Biol 2001; 21: 7318.
  • 7
    Vacca A, Ribatti D, Roccaro AM, Frigeri A, Dammacco F. Bone marrow angiogenesis in patients with active multiple myeloma. Semin Oncol 2001; 28: 54350.DOI: 10.1053/sonc.2001.28604
  • 8
    Vacca A, Frigeri A, Ribatti D, Nicchia GP, Nico B, Ria R, Svelto M, Dammacco F. Microvessel overexpression of aquaporin 1 parallels bone marrow angiogenesis in patients with active multiple myeloma. Br J Haematol 2001; 113: 41521.DOI: 10.1046/j.1365-2141.2001.02738.x
  • 9
    Jaffe EA, Hoyer LW, Nachman RL. Synthesis of von Willebrand factor by cultured human endothelial cells. Proc Natl Acad Sci USA 1974; 71: 19069.
  • 10
    Federici AB, Mannucci PM. Optimizing therapy with Factor VIII/Von Willebrand factor concentrates in von Willebrand disease. Haemophilia 1988; 4 (Suppl. 3): 710.DOI: 10.1046/j.1365-2516.1998.0040s3007.x